NASDAQ
LENZ Therapeutics, Inc. (LENZ) has a current ratio of 13.80x as of Monday, May 25, 2026. This represents a 26.79% increase compared to its 12-month average of 10.88x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.